Memory B cell dynamics in the gut mucosa
- Funded by European Commission
- Total publications:0 publications
Grant number: 101032066
Grant search
Key facts
Disease
Salmonella infection, OtherStart & end year
20222024Known Financial Commitments (USD)
$189,011.53Funder
European CommissionPrincipal Investigator
N/A
Research Location
FranceLead Research Institution
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Salmonellosis is one of the most common and widespread food-borne diseases worldwide. This disease, caused by the gram-negative bacteria Salmonella, affects millions of people every year, leading to more than one hundred thousand deaths around the world. Currently, there is no licensed vaccine against Salmonella to face out this health issue. At present, most licensed human vaccines rely on the induction of long-lived memory lymphocytes. Memory B cells are a key part of this strategy, as they can rapidly differentiate into antibody-secreting cells and neutralize pathogens in case of future exposures. Despite their protective role, we have very limited knowledge on the dynamics of memory B cells in the context of gastrointestinal infection. GUT-MBC aims to unravel the developmental kinetics, spatial distribution and tissue diversity of memory B cells in the gastrointestinal tract upon Salmonella infection. To achieve this goal, I will take advantage of a transgenic mouse line to track memory B cells in vivo, gastrointestinal infection models, multiparametric flow cytometry, cutting edge imaging techniques and single-cell RNA-seq. Understanding how memory B cells are generated and maintained in the gut mucosa and associated lymphoid tissues upon infection is critical for the future design of protective vaccines against Salmonella and other emerging enteric pathogens.